Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Suppression of cell migration by phospholipase C-related catalytically inactive protein-dependent modulation of PI3K signalling.

Asano S, Taniguchi Y, Yamawaki Y, Gao J, Harada K, Takeuchi H, Hirata M, Kanematsu T.

Sci Rep. 2017 Jul 14;7(1):5408. doi: 10.1038/s41598-017-05908-7.

2.

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.

Moleirinho S, Hoxha S, Mandati V, Curtale G, Troutman S, Ehmer U, Kissil JL.

Elife. 2017 May 3;6. pii: e23966. doi: 10.7554/eLife.23966.

3.

Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP.

Lv M, Li S, Luo C, Zhang X, Shen Y, Sui YX, Wang F, Wang X, Yang J, Liu P, Yang J.

Oncotarget. 2016 Mar 15;7(11):12393-403. doi: 10.18632/oncotarget.7161.

4.

All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Sangodkar J, Farrington CC, McClinch K, Galsky MD, Kastrinsky DB, Narla G.

FEBS J. 2016 Mar;283(6):1004-24. doi: 10.1111/febs.13573. Epub 2015 Nov 14. Review.

5.

Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study.

Raffield LM, Cox AJ, Hugenschmidt CE, Freedman BI, Langefeld CD, Williamson JD, Hsu FC, Maldjian JA, Bowden DW.

Neurobiol Aging. 2015 Mar;36(3):1602.e7-15. doi: 10.1016/j.neurobiolaging.2014.11.008. Epub 2014 Nov 20.

6.

Genetic defects in dolichol metabolism.

Buczkowska A, Swiezewska E, Lefeber DJ.

J Inherit Metab Dis. 2015 Jan;38(1):157-69. doi: 10.1007/s10545-014-9760-1. Epub 2014 Oct 1. Review.

7.

Phospholipase C-related catalytically inactive protein (PRIP) controls KIF5B-mediated insulin secretion.

Asano S, Nemoto T, Kitayama T, Harada K, Zhang J, Harada K, Tanida I, Hirata M, Kanematsu T.

Biol Open. 2014 May 8;3(6):463-74. doi: 10.1242/bio.20147591.

8.

The role of SON in splicing, development, and disease.

Lu X, Ng HH, Bubulya PA.

Wiley Interdiscip Rev RNA. 2014 Sep-Oct;5(5):637-46. doi: 10.1002/wrna.1235. Epub 2014 Apr 30. Review.

9.
10.

The Angiomotins--from discovery to function.

Moleirinho S, Guerrant W, Kissil JL.

FEBS Lett. 2014 Aug 19;588(16):2693-703. doi: 10.1016/j.febslet.2014.02.006. Epub 2014 Feb 15. Review.

11.

Further delineation of the SATB2 phenotype.

Döcker D, Schubach M, Menzel M, Munz M, Spaich C, Biskup S, Bartholdi D.

Eur J Hum Genet. 2014 Aug;22(8):1034-9. doi: 10.1038/ejhg.2013.280. Epub 2013 Dec 4.

12.

Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.

Jeong AL, Lee S, Park JS, Han S, Jang CY, Lim JS, Lee MS, Yang Y.

J Biol Chem. 2014 Jan 3;289(1):28-40. doi: 10.1074/jbc.M113.507954. Epub 2013 Nov 8.

13.

Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).

Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD, Foroud T, Farrer LA, Schellenberg GD, George-Hyslop PS, Mayeux R; Alzheimer's Disease Genetics Consortium (ADGC).

Transl Psychiatry. 2013 May 14;3:e256. doi: 10.1038/tp.2013.13.

14.

Mammalian P4-ATPases and ABC transporters and their role in phospholipid transport.

Coleman JA, Quazi F, Molday RS.

Biochim Biophys Acta. 2013 Mar;1831(3):555-74. doi: 10.1016/j.bbalip.2012.10.006. Epub 2012 Oct 26. Review.

15.

Impact of genetic variation in SORCS1 on memory retention.

Reitz C, Lee JH, Rogers RS, Mayeux R.

PLoS One. 2011;6(10):e24588. doi: 10.1371/journal.pone.0024588. Epub 2011 Oct 26.

16.

Kazrin, and its binding partners ARVCF- and delta-catenin, are required for Xenopus laevis craniofacial development.

Cho K, Lee M, Gu D, Munoz WA, Ji H, Kloc M, McCrea PD.

Dev Dyn. 2011 Dec;240(12):2601-12. doi: 10.1002/dvdy.22721. Epub 2011 Oct 25.

17.

Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation.

Tsutsumi K, Matsuda M, Kotani M, Mizokami A, Murakami A, Takahashi I, Terada Y, Kanematsu T, Fukami K, Takenawa T, Jimi E, Hirata M.

J Biol Chem. 2011 Sep 2;286(35):31032-42. doi: 10.1074/jbc.M111.235903. Epub 2011 Jul 11.

18.

The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway.

Gupta-Rossi N, Ortica S, Meas-Yedid V, Heuss S, Moretti J, Olivo-Marin JC, Israël A.

J Biol Chem. 2011 May 27;286(21):18720-30. doi: 10.1074/jbc.M110.190769. Epub 2011 Apr 4.

19.

SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk.

Reitz C, Tokuhiro S, Clark LN, Conrad C, Vonsattel JP, Hazrati LN, Palotás A, Lantigua R, Medrano M, Z Jiménez-Velázquez I, Vardarajan B, Simkin I, Haines JL, Pericak-Vance MA, Farrer LA, Lee JH, Rogaeva E, George-Hyslop PS, Mayeux R.

Ann Neurol. 2011 Jan;69(1):47-64. doi: 10.1002/ana.22308.

20.

Xenopus Kazrin interacts with ARVCF-catenin, spectrin and p190B RhoGAP, and modulates RhoA activity and epithelial integrity.

Cho K, Vaught TG, Ji H, Gu D, Papasakelariou-Yared C, Horstmann N, Jennings JM, Lee M, Sevilla LM, Kloc M, Reynolds AB, Watt FM, Brennan RG, Kowalczyk AP, McCrea PD.

J Cell Sci. 2010 Dec 1;123(Pt 23):4128-44. doi: 10.1242/jcs.072041. Epub 2010 Nov 9.

Supplemental Content

Support Center